Memorial Sloan Kettering Cancer Center

203 articles about Memorial Sloan Kettering Cancer Center

• OSE Immunotherapeutics Announces Strategic Multi-Year Research Collaboration With Memorial Sloan-Kettering Cancer Center In New York

  6/12/2017

• FDA Calls Y-mAbs, Memorial Sloan-Kettering Cancer Center's Pediatric Cancer Drug a Breakthrough

  6/8/2017

• ACEA Biosciences, Inc. Announces Collaboration With Memorial Sloan-Kettering Cancer Center On Personalized CAR T Cell Therapy

  6/5/2017

• Royal Philips Electronics N.V. And Memorial Sloan-Kettering Cancer Center Announce Research Agreement To Jointly Develop Advanced Genome Analytics For Precision Oncology

  6/1/2017

• MabVax Therapeutics Signs Research Agreement With Memorial Sloan-Kettering Cancer Center To Develop Novel CAR T-Cell Based Anti-Cancer Immunotherapies For Treatment Of Pancreatic And Small Cell Lung Cancers

  5/31/2017

• Immune-Onc Therapeutics Announces Licensing And Collaboration With Albert Einstein College of Medicine And Memorial Sloan-Kettering Cancer Center To Develop Novel Cancer Immunotherapy

  3/28/2017

• Karolinska Development AB Aprea Announces Research Collaboration With Memorial Sloan-Kettering Cancer Center

  3/22/2017

• Aprea Announces Research Collaboration With Memorial Sloan-Kettering Cancer Center

  3/22/2017

• Lin Bioscience Licenses A Novel Anti-Cancer Therapy For Hematological Malignancies And Solid Tumors From Columbia University And Memorial Sloan-Kettering Cancer Center

  3/3/2017

• Memorial Sloan-Kettering Cancer Center To Offer DigniCap Scalp Cooling Device In New York Metro Area Locations

  2/13/2017

• Study From Memorial Sloan-Kettering Cancer Center And Epic Sciences Shows Only Nuclear-Localized AR-V7 Is Predictive Of Therapy Benefit For Patients With Metastatic Prostate Cancer

  1/6/2017

• Multiple Myeloma Research Foundation (MMRF) And Memorial Sloan-Kettering Cancer Center Collaborate On Minimal Residual Disease (MRD) Study In Multiple Myeloma

  9/13/2016

• Juno Announces Multiple Myeloma Partnership With Memorial Sloan-Kettering Cancer Center And Eureka Therapeutics For Developing CAR T Cell Immunotherapy Against Multiple Novel Targets

  8/5/2016

• John R. Gunn, Former Chief Operating Officer Of Berkeley Lights, Joins Memorial Sloan-Kettering Cancer Center' Board Of Directors

  8/3/2016

• Data In The Lancet Show Olaratumab Plus Doxorubicin Offered 11.8-Month Increase In Overall Survival In Patients With Advanced Soft Tissue Sarcoma, As Reported By Eli Lilly And Memorial Sloan-Kettering Cancer Center Researchers

  6/10/2016

• MabVax Therapeutics Expands Patient Enrollment In Phase I Trial For Treatment Of Pancreatic Cancer To Memorial Sloan-Kettering Cancer Center

  6/7/2016

• Presence Of AR-V7 In Circulating Tumor Cells Validated As Predictive Biomarker For Advanced Prostate Cancer Treatment By Memorial Sloan-Kettering Cancer Center And Epic Sciences

  6/6/2016

• Most Americans Unwilling To Join A Clinical Trial, Memorial Sloan-Kettering Cancer Center Study

  5/26/2016

• Seres Therapeutics Announces Broad Agreement With Memorial Sloan-Kettering Cancer Center To Develop Microbiome Therapeutics For Hematopoietic Stem Cell Transplantation And Immuno-Oncology Treatment

  5/12/2016

• Memorial Sloan-Kettering Cancer Center President And CEO Dr. Craig B. Thompson Keynotes Lasker Lessons In Leadership Workshop

  4/1/2016